CareTrust REIT, Inc. (CTRE) - Q2 2024 Filing Summary
Business Context and Reporting Period
This summary covers the Quarterly Report on Form 10-Q for the period ended June 30, 2024. CareTrust REIT, Inc. is a self-administered REIT focused on acquiring, financing, developing, and owning healthcare real estate, primarily skilled nursing facilities (SNFs), multi-service campuses, assisted living facilities (ALFs), and independent living facilities (ILFs). As of June 30, 2024, the Company owned or held interests in 235 facilities with 25,058 operational beds across 30 states. The portfolio is heavily concentrated in California and Texas. The Company also maintains a significant portfolio of other real estate-related investments, including mortgage and mezzanine loans.
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | YTD 2024 (6 Months) | YTD 2023 (6 Months) |
|---|---|---|---|
| Total Revenues | $68.9 million | $132.0 million | $102.2 million |
| Rental Income | $55.4 million | $108.9 million | $93.9 million |
| Interest & Other Income | $13.5 million | $23.1 million | $8.3 million |
| Net Income (Attributable to CTRE) | $10.8 million | $39.5 million | $18.7 million |
| Diluted EPS | $0.07 | $0.28 | $0.19 |
| Operating Cash Flow (YTD) | $101.8 million | ||
| Cash & Equivalents (End of Period) | $495.1 million | ||
| Total Debt (Principal) | $675.0 million | ||
| Dividends Declared (Q2) | $0.29 per share |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 34% year-over-year (YTD) to $132.0 million. Rental income rose 16% due to new acquisitions and rent escalators. Interest and other income surged 179% to $23.1 million, driven by new loan originations and higher yields on money market funds.
- Impairment Charges: The Company recognized $28.5 million in impairment charges for the six months ended June 30, 2024, compared to $23.3 million in the prior year period. This relates to properties classified as "held for sale" being marked down to fair value less costs to sell.
- Interest Expense: Interest expense decreased 19% YTD to $16.9 million, primarily due to a reduction in borrowings under the Revolving Credit Facility, partially offset by higher rates on the Term Loan and interest on a new secured borrowing.
- Balance Sheet Expansion: Total assets grew to $2.70 billion from $2.08 billion at year-end 2023, driven by $208.4 million in real estate acquisitions and $253.8 million in new loan originations.
Outlook, Risks, and Management Commentary
- Capital Deployment: The Company remains active in the market, acquiring 12 properties and originating over $555 million in loans and preferred equity investments between January and August 2024. It utilized its At-The-Market (ATM) equity program to raise approximately $572 million net in the first half of 2024.
- Regulatory Risks: Management highlighted significant regulatory headwinds, including California Senate Bill 525 (minimum wage increases for healthcare workers) and new CMS staffing requirements. These unfunded mandates are expected to increase tenant operating costs and may impact their ability to meet lease obligations.
- Market Conditions: Elevated interest rates and inflation continue to increase the Company's cost of capital and tenant operating expenses. Occupancy levels in seniors housing (ALFs/ILFs) remain below pre-pandemic levels, while SNF occupancy has stabilized.
- Liquidity: The Company maintains strong liquidity with $495 million in cash and $600 million available under its revolving credit facility. It expects to meet obligations for the next 12 months through operating cash flows and existing financing.
- Subsequent Events: On July 30, 2024, the Company repaid a $75 million secured borrowing. On August 1, 2024, it originated a $260 million mortgage loan and a $43 million preferred equity investment.
Investor Verification Checklist
- Impairment Sustainability: Verify the valuation assumptions for the 20 facilities currently held for sale ($28.8 million carrying value) and the potential for further write-downs if market conditions deteriorate.
- Tenant Concentration: Review the financial health of major tenants, specifically Ensign (29% of revenue) and Priority Management Group (13% of revenue), given the regulatory cost pressures they face.
- Loan Portfolio Quality: Assess the credit quality of the rapidly expanding loan portfolio ($433.5 million carrying value), particularly the exposure to floating-rate loans and the impact of rising interest rates on borrower solvency.
- Regulatory Impact: Monitor the implementation timeline and financial impact of California SB 525 and CMS staffing rules on the Company's California portfolio (30% of revenue).
- Equity Dilution: Track the utilization of the ATM program, which has $193.5 million remaining, and its impact on share count and EPS accretion/dilution.